ORMD-0801

DRUG4 trials

Sponsors

Oramed, Ltd., King Hamad University Hospital, Bahrain

Conditions

Diabetes Mellitus, Type 2Diabetes Type 2T2DM (Type 2 Diabetes Mellitus)

Phase 2

Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

CompletedNCT02496000

Oramed, Ltd.Diabetes Type 2

Start: 2015-07-27End: 2016-09-13Updated: 2019-11-13

A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus

CompletedNCT04564846

Oramed, Ltd.Diabetes Mellitus, Type 2

Start: 2020-11-23End: 2022-06-07Updated: 2024-05-07

Phase 3

A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

TerminatedNCT04754334

Oramed, Ltd.T2DM (Type 2 Diabetes Mellitus)

Start: 2021-03-16End: 2023-01-13Updated: 2023-02-09

Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

King Hamad University Hospital, BahrainDiabetes Mellitus, Type 2

Start: 2021-10-31End: 2022-07-31Target: 608Updated: 2021-03-26